Race Can Affect Breast Cancer Test for Predicting Chemo Benefit

TUESDAY, Feb. 6, 2024 -- The 21-gene breast recurrence score (RS) is valid for predicting chemotherapy benefit for non-Hispanic Black (NHB), Hispanic, and non-Hispanic White (NHW) women with estrogen receptor (ER)-positive, axillary node-negative...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news